MetaCap

Who Owns Apnimed Stock?

NASDAQ: APMDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

18.52+0.30 (+1.65%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
23.44%
Institutional holders
17
  • Institutions 23.4%
  • Insiders 35.6%
  • Public and other 41.0%

Who owns Apnimed stock?

Institutional investors own about 23.4% of Apnimed's shares, spread across 17 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 35.61% of APMD.

Summary generated from market data by MetaCap's automated system. Methodology

Top mutual fund and ETF holders of APMD

Apnimed top fund holders
FundShares% Held
AB CAP FUND, INC.-AB Small Cap Growth Portfolio299.27K0.72%
Fidelity Contrafund126.86K0.30%
Fidelity Select Portfolios-Select Biotechnology Portfolio92.40K0.22%
Fidelity Contrafund-Fidelity Contrafund K626.50K0.06%
Variable Insurance Products Fund II-VIP Contrafund Portfolio11.40K0.03%
Voya Investors Trust-VY(R) JPMorgan Small Cap Core Equity Portfolio10.89K0.03%
Fidelity Contrafund-Fidelity Advisor New Insights Fund10.40K0.02%
AB VARIABLE PRODUCTS SERIES FUND, INC.-AB Small Cap Growth Portfolio6.09K0.01%
Fidelity Contrafund-Fidelity Series Opportunistic Insights Fund5.80K0.01%
ProShares Trust-ProShares Russell 2000 High Income ETF7190.00%

Frequently asked questions

What percentage of Apnimed is owned by institutions?

Institutions own about 23.4% of APMD shares and 36.4% of the public float.

How much of Apnimed do insiders own?

Insiders, such as officers and directors, own about 35.61% of APMD shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related